Correlation Between Hookipa Pharma and Artiva Biotherapeutics,
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and Artiva Biotherapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and Artiva Biotherapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and Artiva Biotherapeutics, Common, you can compare the effects of market volatilities on Hookipa Pharma and Artiva Biotherapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of Artiva Biotherapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and Artiva Biotherapeutics,.
Diversification Opportunities for Hookipa Pharma and Artiva Biotherapeutics,
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Hookipa and Artiva is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and Artiva Biotherapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artiva Biotherapeutics, and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with Artiva Biotherapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artiva Biotherapeutics, has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and Artiva Biotherapeutics, go up and down completely randomly.
Pair Corralation between Hookipa Pharma and Artiva Biotherapeutics,
Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the Artiva Biotherapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Hookipa Pharma is 1.28 times less risky than Artiva Biotherapeutics,. The stock trades about -0.18 of its potential returns per unit of risk. The Artiva Biotherapeutics, Common is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 1,200 in Artiva Biotherapeutics, Common on September 26, 2024 and sell it today you would lose (81.00) from holding Artiva Biotherapeutics, Common or give up 6.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 88.89% |
| Values | Daily Returns |
Hookipa Pharma vs. Artiva Biotherapeutics, Common
Performance |
| Timeline |
| Hookipa Pharma |
| Artiva Biotherapeutics, |
Hookipa Pharma and Artiva Biotherapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hookipa Pharma and Artiva Biotherapeutics,
The main advantage of trading using opposite Hookipa Pharma and Artiva Biotherapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, Artiva Biotherapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artiva Biotherapeutics, will offset losses from the drop in Artiva Biotherapeutics,'s long position.| Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
| Artiva Biotherapeutics, vs. Fate Therapeutics | Artiva Biotherapeutics, vs. Caribou Biosciences | Artiva Biotherapeutics, vs. Karyopharm Therapeutics | Artiva Biotherapeutics, vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |